DRAGARWQHospital
Dr Agarwals Eye Hospital Ltd — Profit & Loss Statement
₹4704.40
-0.43%
Dr Agarwals Eye Hospital Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -0.05 Cr | 0.06 Cr | — |
| Tax Rate For Calcs | 0.23 | 0.26 | 0.25 | 0.25 | — |
| Normalized EBITDA | 123.59 Cr | 96.03 Cr | 76.58 Cr | 58.60 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 54.65 Cr | 46.36 Cr | 36.92 Cr | 24.10 Cr | — |
| Reconciled Depreciation | 39.45 Cr | 26.61 Cr | 20.18 Cr | 20.39 Cr | — |
| Reconciled Cost Of Revenue | 167.94 Cr | 134.33 Cr | 114.22 Cr | 85.15 Cr | — |
| EBITDA | 123.59 Cr | 96.03 Cr | 76.38 Cr | 58.82 Cr | — |
| EBIT | 84.14 Cr | 69.42 Cr | 56.20 Cr | 38.43 Cr | — |
| Net Interest Income | -13.44 Cr | -7.17 Cr | -7.26 Cr | -6.67 Cr | — |
| Interest Expense | 13.44 Cr | 7.17 Cr | 6.80 Cr | 6.12 Cr | — |
| Normalized Income | 54.65 Cr | 46.36 Cr | 37.07 Cr | 23.94 Cr | — |
| Net Income From Continuing And Discontinued Operation | 54.65 Cr | 46.36 Cr | 36.92 Cr | 24.10 Cr | — |
| Total Expenses | 318.10 Cr | 254.85 Cr | 210.26 Cr | 162.69 Cr | — |
| Diluted Average Shares | 0.47 Cr | 0.47 Cr | 0.47 Cr | 0.47 Cr | — |
| Basic Average Shares | 0.47 Cr | 0.47 Cr | 0.47 Cr | 0.47 Cr | — |
| Diluted EPS | 116.28 | 98.64 | 78.55 | 51.29 | — |
| Basic EPS | 116.28 | 98.64 | 78.55 | 51.29 | — |
| Diluted NI Availto Com Stockholders | 54.65 Cr | 46.36 Cr | 36.92 Cr | 24.10 Cr | — |
| Net Income Common Stockholders | 54.65 Cr | 46.36 Cr | 36.92 Cr | 24.10 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 54.65 Cr | 46.36 Cr | 36.92 Cr | 24.10 Cr | — |
| Net Income Including Noncontrolling Interests | 54.65 Cr | 46.36 Cr | 36.92 Cr | 24.10 Cr | — |
| Net Income Continuous Operations | 54.65 Cr | 46.36 Cr | 36.92 Cr | 24.10 Cr | — |
| Tax Provision | 16.05 Cr | 15.89 Cr | 12.48 Cr | 8.21 Cr | — |
| Pretax Income | 70.70 Cr | 62.25 Cr | 49.40 Cr | 32.31 Cr | — |
| Other Non Operating Income Expenses | 5.09 Cr | 4.97 Cr | 0.50 Cr | 0.50 Cr | — |
| Net Non Operating Interest Income Expense | -13.44 Cr | -7.17 Cr | -7.26 Cr | -6.67 Cr | — |
| Interest Expense Non Operating | 13.44 Cr | 7.17 Cr | 6.80 Cr | 6.12 Cr | — |
| Operating Income | 79.05 Cr | 64.45 Cr | 56.47 Cr | 38.27 Cr | — |
| Operating Expense | 150.16 Cr | 120.52 Cr | 96.04 Cr | 77.54 Cr | — |
| Other Operating Expenses | 57.44 Cr | 45.54 Cr | 21.54 Cr | 17.09 Cr | — |
| Depreciation And Amortization In Income Statement | 39.45 Cr | 26.61 Cr | 20.18 Cr | 20.39 Cr | — |
| Depreciation Income Statement | 39.45 Cr | 26.61 Cr | 19.66 Cr | 19.77 Cr | — |
| Selling General And Administration | 53.27 Cr | 48.37 Cr | 52.47 Cr | 37.42 Cr | — |
| General And Administrative Expense | 53.27 Cr | 48.37 Cr | 42.24 Cr | 31.69 Cr | — |
| Gross Profit | 229.21 Cr | 184.97 Cr | 152.51 Cr | 115.81 Cr | — |
| Cost Of Revenue | 167.94 Cr | 134.33 Cr | 114.22 Cr | 85.15 Cr | — |
| Total Revenue | 397.15 Cr | 319.30 Cr | 266.73 Cr | 200.96 Cr | — |
| Operating Revenue | 397.15 Cr | 319.30 Cr | 266.73 Cr | 200.96 Cr | — |
| Total Unusual Items | — | -0.44 Cr | -0.20 Cr | 0.22 Cr | 1.12 Cr |
| Total Unusual Items Excluding Goodwill | — | -0.44 Cr | -0.20 Cr | 0.22 Cr | 1.12 Cr |
| Interest Income | — | 1.95 Cr | 0.78 Cr | 0.54 Cr | 0.13 Cr |
| Rent Expense Supplemental | — | 3.22 Cr | 3.22 Cr | 2.89 Cr | 3.18 Cr |
| Special Income Charges | — | -0.44 Cr | -0.20 Cr | 0.22 Cr | 1.12 Cr |
| Other Special Charges | — | 0.23 Cr | -0.03 Cr | -0.22 Cr | 0.02 Cr |
| Write Off | — | 0.21 Cr | 0.23 Cr | 0.00 | -1.14 Cr |
| Total Other Finance Cost | — | 1.20 Cr | 1.24 Cr | 1.09 Cr | 0.83 Cr |
| Interest Income Non Operating | — | 1.95 Cr | 0.78 Cr | 0.54 Cr | 0.13 Cr |
| Amortization | — | 0.35 Cr | 0.52 Cr | 0.62 Cr | 1.02 Cr |
| Selling And Marketing Expense | — | 12.74 Cr | 10.23 Cr | 5.73 Cr | 2.78 Cr |
| Rent And Landing Fees | — | 3.22 Cr | 3.22 Cr | 2.89 Cr | 3.18 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Dr Agarwals Eye Hospital Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.